Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Cedars-Sinai researchers detail events that enable brain tumors to weaken immune system


In an article appearing in a special issue of the Journal of Neuro-oncology, researchers at Cedars-Sinai Medical Center’s Maxine Dunitz Neurosurgical Institute describe a complex cell-level process that allows malignant brain tumors to protect themselves by damaging the thymus, rapidly degrading the immune system. In a second article, Institute scientists identify a molecular mechanism that causes cell death of cancer-fighting lymphocytes as they infiltrate a brain tumor.

"We are dissecting and better understanding the mechanisms that enable tumors to evade destruction by the immune system. This gives us new tools in our fight against brain cancer, to essentially correct these deficits and further enhance the ability of the immune system, not only to detect but also to destroy brain tumors," said Keith L. Black, M.D., director of the Institute, Cedars-Sinai’s Division of Neurosurgery and the Comprehensive Brain Tumor Program.

In an animal study, researchers found that intracranial gliomas – aggressive brain tumors – damage the thymus, the gland responsible for the development and potency of the immune system’s T cells. As the thymus shrinks and its normal structure becomes distorted, many of the thymocytes – the "immature" cells destined to become functional T cells potentially capable of destroying a variety of antigens – undergo a process that weakens and kills them.

Thymocytes are derived from bone marrow and as they travel through the thymus they go through a natural selection process that removes the weakest and prepares the strongest to become lymphocytes that can later adapt as needed to meet a variety of immune challenges. When an intracranial glioma is present, the researchers found, the number of healthy T cells leaving the thymus is dramatically reduced, preventing a large-scale attack on the tumor.

Changes to the thymus and "recent thymic emigrant" (RTE) T cells are similar to those seen in advanced cases of AIDS, in which HIV causes thymocyte death. In glioma progression, researchers believe glucocorticoids, hormones produced by the adrenal glands, are involved in the loss of thymocytes.

The authors noted that physical stress on the body may play a significant role because it causes the release of glucocorticoids. In rats that had their adrenal glands removed to reduce the production of glucocorticoids, the damaging effects were significantly less pronounced.

This finding may also have implications for the way physicians currently treat swelling of brain tissue in patients who have brain tumors. Synthetic glucocorticoids administered to reduce intracranial pressure are highly effective for this purpose but their impact on the thymus and T cells may be further inhibiting an already embattled immune system.

Although CD8(+) cells are produced elsewhere in the body, those originating in the thymus appear to have special relevance in anti-glioma immunity, according to the study.

"It appears that these recent thymic emigrant T cells preferentially home to gliomas or they have an enhanced anti-tumor activity that allows them to home there preferentially," said Christopher J. Wheeler, Ph.D., research scientist and corresponding author on both papers.

"In a sense, we see two mechanisms working against each other," said Dr. Wheeler, "Recent thymic emigrant T cells are homing to the tumor, but there is a subversion of thymic function by the tumor itself. Therefore, while we have those cells preferentially homing – they’re enriched relative to other cells – we don’t have a lot of those cells to begin with."

According to the second paper, the tumor’s immediate environment also changes in a way that thwarts an effective tumor-infiltrating response.

The population of "types" of T cells found in aggressive, malignant tumors was out of balance compared to the response seen in benign tumors. Benign tumors had a high proportion of CD8(+) T cells compared to CD4(+) T cells, which is an indication of a strong tumor-killing immune response. In contrast, nearly all gliomas exhibited greater proportions of CD4(+) relative to CD8(+) T cells.

This manipulation of tumor-infiltrating lymphocytes does not appear to be controlled by the tumor cells themselves but at least to some extent by properties of surrounding tissue, and the ratio correlated directly with the involvement of specific protein molecules detected in nearby cells.

The suspect proteins, Fas ligand (FasL) and Fas, exist in normal brain and blood vessel lining tissue and play a role in immune system regulation. Based on this study, however, they also are expressed on tumor-associated endothelial cells where they may intercept the cancer-fighting T lymphocytes. Endothelial cells make up the lining of blood vessels.

According to the article, increasing levels of endothelial FasL correlated with decreasing proportions of tumor-infiltrating cytotoxic T lymphocytes – tumor-killing immune cells. This suggests the possibility that Fas ligand contributes to a tumor’s ability to evade the immune system.

Taken together, the studies indicate that malignant brain tumors are protected against immunity because the number of potential T cells is reduced in the thymus, and those that initially survive may later be damaged or destroyed.

Malignant gliomas continue to be considered incurable with a short length of survival, although researchers at the Institute have devised a vaccine strategy that has provided encouraging results in early trials. The treatment, called dendritic cell immunotherapy, assists the immune system in recognizing cancer cells as targets for attack, but it depends on the existence of healthy T cells to launch and sustain the immune response.

"The immune system will try to fight off a malignant brain tumor but because it does not accomplish this very effectively, we’re trying to enhance its ability with our cancer vaccine and other therapies," said Dr. Black, who holds Cedars-Sinai’s Ruth and Lawrence Harvey Chair in Neuroscience.

"We know that the strongest predictor of survival in patients with brain tumors is age. The younger immune system is better able to put up resistance than an older immune system because the thymus naturally becomes weaker and it has fewer precursors of immune cells to recruit in the fight against the tumor. We observe a strong correlation between the survival of a tumor and patient age, which is directly proportional to the number of T cells produced by the thymus."

The current studies provide insights that may lead to methods to prevent loss of T cells, repair those that become damaged, and strengthen and replenish the supply needed to contain and destroy brain tumors.

Sandra Van | EurekAlert!
Further information:

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Space observation with radar to secure Germany's space infrastructure

Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.

The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

New solar solutions for sustainable buildings and cities

23.03.2018 | Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

Latest News

For graphite pellets, just add elbow grease

23.03.2018 | Materials Sciences

Unique communication strategy discovered in stem cell pathway controlling plant growth

23.03.2018 | Agricultural and Forestry Science

Sharpening the X-ray view of the nanocosm

23.03.2018 | Physics and Astronomy

Science & Research
Overview of more VideoLinks >>>